Total Payments
$807,499
2024 Payments
$47,801
Companies
51
Transactions
1,449
Medicare Patients
4,339
Medicare Billing
$500,863
Payment Breakdown by Category
Other$587,985 (72.8%)
Consulting$116,266 (14.4%)
Travel$72,442 (9.0%)
Food & Beverage$30,700 (3.8%)
Education$105.14 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $584,985 | 222 | 72.4% |
| Consulting Fee | $116,266 | 46 | 14.4% |
| Travel and Lodging | $72,442 | 214 | 9.0% |
| Food and Beverage | $30,700 | 960 | 3.8% |
| Honoraria | $3,000 | 2 | 0.4% |
| Education | $105.14 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $285,598 | 353 | $0 (2024) |
| GENZYME CORPORATION | $138,894 | 164 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $82,080 | 70 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $77,461 | 176 | $0 (2024) |
| TG Therapeutics, Inc. | $74,249 | 61 | $0 (2024) |
| Genentech USA, Inc. | $62,102 | 53 | $0 (2024) |
| Celgene Corporation | $52,514 | 95 | $0 (2024) |
| EMD Serono, Inc. | $11,643 | 170 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $8,276 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $6,164 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,801 | 172 | TG Therapeutics, Inc. ($32,206) |
| 2023 | $82,914 | 241 | TG THERAPEUTICS, INC. ($42,043) |
| 2022 | $78,547 | 183 | E.R. Squibb & Sons, L.L.C. ($46,435) |
| 2021 | $48,388 | 80 | Celgene Corporation ($19,565) |
| 2020 | $24,182 | 64 | Celgene Corporation ($15,871) |
| 2019 | $150,657 | 223 | Novartis Pharmaceuticals Corporation ($64,418) |
| 2018 | $166,738 | 201 | Biogen, Inc. ($94,587) |
| 2017 | $208,271 | 285 | GENZYME CORPORATION ($103,968) |
All Payment Transactions
1,449 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Neuroscience | ||||||
| 12/20/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neurology | ||||||
| 12/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.43 | General |
| 12/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.73 | General |
| 12/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.17 | General |
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $50.12 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $31.39 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,835.00 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Immunology | ||||||
| 11/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 11/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $46.54 | General |
| 11/18/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Neurology | ||||||
| 11/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $1.27 | General |
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Neurology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $860.77 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $307.81 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.03 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,035 | 1,392 | $209,619 | $123,015 |
| 2022 | 13 | 1,032 | 3,599 | $230,581 | $129,325 |
| 2021 | 15 | 1,123 | 6,446 | $236,300 | $131,199 |
| 2020 | 15 | 1,149 | 8,802 | $217,369 | $117,324 |
Total Patients
4,339
Total Services
20,239
Medicare Billing
$500,863
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 358 | 579 | $79,494 | $51,843 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 354 | $33,796 | $21,406 | 63.3% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 77 | 81 | $20,780 | $11,629 | 56.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 87 | $16,475 | $11,182 | 67.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $13,669 | $9,311 | 68.1% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 43 | 43 | $12,813 | $4,336 | 33.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 34 | 37 | $3,853 | $2,795 | 72.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,939 | $2,133 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 33 | $5,544 | $1,888 | 34.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 29 | 37 | $2,428 | $1,730 | 71.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 21 | $5,067 | $1,722 | 34.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,423 | $1,601 | 29.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 11 | 11 | $1,755 | $1,062 | 60.5% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 15 | 15 | $582.24 | $378.00 | 64.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 332 | 533 | $75,082 | $48,580 | 64.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 310 | 483 | $47,154 | $28,771 | 61.0% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 65 | 68 | $18,195 | $10,607 | 58.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 75 | $14,981 | $9,766 | 65.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 42 | $18,606 | $5,910 | 31.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $6,902 | $4,445 | 64.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 59 | $13,452 | $4,348 | 32.3% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2022 | 32 | 32 | $9,052 | $3,634 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $5,327 | $3,375 | 63.4% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 14 | 14 | $5,062 | $3,215 | 63.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 27 | 37 | $3,850 | $2,980 | 77.4% |
About Dr. Douglas Stuart, M.D
Dr. Douglas Stuart, M.D is a Neurology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548251572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Stuart, M.D has received a total of $807,499 in payments from pharmaceutical and medical device companies, with $47,801 received in 2024. These payments were reported across 1,449 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($584,985).
As a Medicare-enrolled provider, Stuart has provided services to 4,339 Medicare beneficiaries, totaling 20,239 services with total Medicare billing of $500,863. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Atlanta, GA
- Active Since 10/31/2005
- Last Updated 02/15/2018
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1548251572
Products in Payments
- TECFIDERA (Drug) $147,593
- ZEPOSIA (Drug) $115,588
- BRIUMVI (Drug) $74,249
- TYSABRI (Biological) $72,638
- AUBAGIO (Drug) $71,560
- LEMTRADA (Drug) $67,299
- MAYZENT (Drug) $42,740
- OCREVUS (Biological) $41,853
- Non-Covered Product (Drug) $20,037
- VUMERITY (Drug) $18,429
- ZINBRYTA (Biological) $16,334
- Ozanimod (Drug) $12,426
- Tysabri (Biological) $8,116
- ULTOMIRIS (Biological) $7,473
- Mavenclad (Drug) $6,322
- COPAXONE (Drug) $5,880
- UPLIZNA (Drug) $3,730
- KESIMPTA (Drug) $1,349
- MAVENCLAD (Drug) $672.87
- GILENYA (Drug) $352.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Atlanta
Dr. Joash Lazarus, M.d, M.D
Neurology — Payments: $1.0M
Neurology $1.0M
Robert Gilbert, M.d, M.D
Neurology — Payments: $946,678
Neurology $946,678
Frank Berenson, Md, MD
Neurology — Payments: $628,973
Neurology $628,973
Julio Flamini, M.d, M.D
Neurology — Payments: $554,096
Neurology $554,096
Lawrence Seiden, M.d, M.D
Neurology — Payments: $318,322
Neurology $318,322
Andrei Serbanescu, M.d, M.D
Neurology — Payments: $317,980
Neurology $317,980